##, P < 0.01 (3-MA+rapamycin+MK-2206 group vs rapamycin+MK-2206 group). the development of some NB cell lines, especially people that have BF-168 MYCN amplification (Li et al., 2012). MYCN can be an oncogene and encodes a transcription aspect. MYCN amplification continues to be utilized to determine NB prognosis and resulted in poor therapeutic impact and low … Continue reading ##, P < 0